- HTRS •
- 15 March, 2025 •
- •
Clinical Outcomes Over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents from North America with Severe Hemophilia A in the Phase 3 XTEND-ed Long-Term Extension Study
Janice Staber, Angela Weyand, Umer Khan, Jennifer Dumont, Lara Mamikonian, Davide Matino
Available materials